Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of Winrevair (sotatercept) for the treatment of adult patients with World Health Organization (WHO)
Keep Up to Date with our Weekly Newsletter
SFDA approves ‘Winrevair’ for rare pulmonary hypertension treatment
